Brainstorm Cell Therapeutics Inc. (BCLI)

Free Cash Flow

-$4.06M

TTM · Period ending: · USD

BCLI logo

BCLI Free Cash Flow

Latest reported-$4.06M
BCLI TTM Free Cash Flow (-$9.70K → -$4.06M)
High-resolution chart · PNG

BCLI free cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Brainstorm Cell Therapeutics Inc. Free Cash Flow — Trailing twelve months (TTM) (USD)
Period endingFree Cash Flow (USD)
-4,057,000
-6,664,000
-6,975,000
-7,283,000
-9,480,000
-7,661,000
-9,093,000
-11,330,000
-14,458,000
-19,553,000
-20,476,000
-21,839,000
-20,263,000
-19,638,000
-19,349,000
-20,244,000
-22,090,000
-21,294,000
-26,595,000
-28,863,000
-29,178,000
-29,533,000
-35,571,000
-31,384,000
-28,100,000
-25,917,000
-11,720,000
-11,927,000
-14,794,000
-11,425,000
-12,757,000
-11,923,000
-1,571,000
-3,073,000
-2,544,000
-750,000
-4,793,000
-4,596,000
-5,961,000
-6,066,000
-8,322,000
-8,523,000
-7,453,000
-8,219,000
-6,796,000
-6,100,000
-4,648,000
-4,193,000
-3,818,000
-3,957,000
-4,162,000
-3,235,000
-3,579,000
-2,898,000
-3,006,000
-2,795,000
-2,605,000
-2,977,000
-2,271,000
-2,340,000
-1,843,000
-1,564,000
-2,074,000
-1,989,000
-1,801,000
-1,338,000
-898,000
-771,000
-1,005,000
-1,420,000
-2,081,000
-2,230,000
-2,826,000
-2,658,588
-2,121,000
-1,905,513
-1,187,824
-1,331,116
-1,461,928
-1,535,547
-1,538,715
-1,461,928
-1,243,352
-1,382,504
-1,036,685
-654,894
-464,216
15,129
-5,370
-15,436
-9,696
-4,423
-5,792
-7,012
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.